Be a Smart Investor
Monday, June 4, 2018
Array BioPharma Provides Updated Results From Phase 3 Columbus Trial
Array BioPharma Inc. (ARRY) on Monday announced updated results from the Phase 3 COLUMBUS trial in BRAF-mutant advanced melanoma.
from RTT - Biotech https://ift.tt/2Ln7o4P
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment